- Enzymes
- Kits
- Reagents
- Instruments
Glycomics Glycobiology Market size was valued at USD 1,127.6 million in 2022 and is expected to reach a value of USD 2,736.1 million by 2029, growing at a CAGR of 13.5% from 2023-2029. The global market provides a detailed overview of the glycomics glycobiology market and that can be segmented by product, application, and end user. By product, the glycomics glycobiology market has been segmented into enzymes, kits, reagents, and instruments. The enzymes segment is likely to be the largest and fastest-growing segment in terms of product. Further, enzymes are sub-segmented into glycosidases, neuraminidases, glycosyltransferases, sialytransferases, and others. Kits are segregated into glycan labeling kits, glycan purification kits, glycan releases kits, and others. Reagents are segmented into glycoporteins, monosaccharides, oligosaccharides, and others. Instruments is segregated into mass spectrometers, HPLC, MALDI-TOF, array systems, and others. Based on application, the glycomics glycobiology market is segmented into drug discovery and development, diagnostics, and others. Among these, the diagnostics segment is expected to have the fastest-growing market during the forecast period 2022-2028. On the basis of end-users, the market is segregated into academic & research institutes, pharmaceutical & biotechnology companies, CROs, and others. The academic & research institutes held considerable market share during the forecast period.
Study Period
Base Year
CAGR
Largest Market
Fastest Growing Market
Expanding the use of glycan in pharmaceutical research and the creation of novel therapies, increasing research and development spending by the pharmaceutical and biotechnology industries, and the need for drugs to treat a variety of serious chronic conditions are some key factors fueling the market growth
The Glycomics/Glycobiology Market is projected to expand at a CAGR of 13.5% during the forecast period
The major players in the global glycomics glycobiology market are Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Agilent Technologies (US), Bruker Corporation (US), New England Biolabs (US), Danaher Corporation (US), Shimadzu Corporation (Japan), Takara Bio, Inc. (Japan), Waters Corporation (US), S-BIO (subsidiary of Sumitomo Bakelite Co. Ltd., Japan), RayBiotech (US), Z Biotech (US), Chemily Glycoscience (US), Dextra Laboratories (UK), Lectenz Bio (US), Ludger Ltd. (UK), Asparia Glycomics S.L. (Spain) and Bio-Techne (US)
Asia Pacific is the fastest-growing region for Glycomics/Glycobiology Market
1. Executive Summary |
2. Global Glycomics/Glycobiology Market Introduction |
2.1. Global Glycomics/Glycobiology Market – Taxonomy |
2.2. Global Glycomics/Glycobiology Market –Definitions |
2.2.1. By Product |
2.2.2. By Application |
2.2.3. By End Use |
2.2.4. By Region |
3. Global Glycomics/Glycobiology Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Global Glycomics/Glycobiology Market Dynamic Factors - Impact Analysis |
3.6. Global Glycomics/Glycobiology Market – Competition Landscape |
4. Global Glycomics/Glycobiology Market Analysis, 2018 - 2022 and Forecast, 2023- 2029 |
4.1. Market Analysis, 2018 - 2022 and Forecast, 2023- 2029 (Revenue, USD Mn) |
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5. Global Glycomics/Glycobiology Market, By Product, 2018 - 2022 and Forecast, 2023- 2029 (Revenue, USD Mn) |
5.1. Enzymes |
5.1.1. Glycosidases |
5.1.2. Market Analysis, 2018 - 2022 and Forecast, 2023- 2029 (Revenue, USD Mn) |
5.1.3. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.4. Market Opportunity Analysis |
5.1.5. Neuraminidases |
5.1.6. Market Analysis, 2018 - 2022 and Forecast, 2023- 2029 (Revenue, USD Mn) |
5.1.7. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.8. Market Opportunity Analysis |
5.1.9. Glycosyltransferases |
5.1.10. Market Analysis, 2018 - 2022 and Forecast, 2023- 2029 (Revenue, USD Mn) |
5.1.11. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.12. Market Opportunity Analysis |
5.1.13. Sialytransferases |
5.1.14. Market Analysis, 2018 - 2022 and Forecast, 2023- 2029 (Revenue, USD Mn) |
5.1.15. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.16. Market Opportunity Analysis |
5.1.17. Others |
5.1.18. Market Analysis, 2018 - 2022 and Forecast, 2023- 2029 (Revenue, USD Mn) |
5.1.19. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.20. Market Opportunity Analysis |
5.2. Kits |
5.2.1. Glycan Labelling Kits |
5.2.2. Market Analysis, 2018 - 2022 and Forecast, 2023- 2029 (Revenue, USD Mn) |
5.2.3. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.4. Market Opportunity Analysis |
5.2.5. Glycan Purification Kits |
5.2.6. Market Analysis, 2018 - 2022 and Forecast, 2023- 2029 (Revenue, USD Mn) |
5.2.7. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.8. Market Opportunity Analysis |
5.2.9. Glycan Releases Kits |
5.2.10. Market Analysis, 2018 - 2022 and Forecast, 2023- 2029 (Revenue, USD Mn) |
5.2.11. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.12. Market Opportunity Analysis |
5.2.13. Others |
5.2.14. Market Analysis, 2018 - 2022 and Forecast, 2023- 2029 (Revenue, USD Mn) |
5.2.15. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.16. Market Opportunity Analysis |
5.3. Reagents |
5.3.1. Glycoporteins |
5.3.2. Market Analysis, 2018 - 2022 and Forecast, 2023- 2029 (Revenue, USD Mn) |
5.3.3. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.4. Market Opportunity Analysis |
5.3.5. Monosaccharides |
5.3.6. Market Analysis, 2018 - 2022 and Forecast, 2023- 2029 (Revenue, USD Mn) |
5.3.7. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.8. Market Opportunity Analysis |
5.3.9. Oligosaccharides |
5.3.10. Market Analysis, 2018 - 2022 and Forecast, 2023- 2029 (Revenue, USD Mn) |
5.3.11. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.12. Market Opportunity Analysis |
5.3.13. Others |
5.3.14. Market Analysis, 2018 - 2022 and Forecast, 2023- 2029 (Revenue, USD Mn) |
5.3.15. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.16. Market Opportunity Analysis |
5.4. Instruments |
5.4.1. Mass Spectrometers |
5.4.2. Market Analysis, 2018 - 2022 and Forecast, 2023- 2029 (Revenue, USD Mn) |
5.4.3. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.4.4. Market Opportunity Analysis |
5.4.5. HPLC |
5.4.6. Market Analysis, 2018 - 2022 and Forecast, 2023- 2029 (Revenue, USD Mn) |
5.4.7. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.4.8. Market Opportunity Analysis |
5.4.9. MALDI-TOF |
5.4.10. Market Analysis, 2018 - 2022 and Forecast, 2023- 2029 (Revenue, USD Mn) |
5.4.11. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.4.12. Market Opportunity Analysis |
5.4.13. Array Systems |
5.4.14. Market Analysis, 2018 - 2022 and Forecast, 2023- 2029 (Revenue, USD Mn) |
5.4.15. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.4.16. Market Opportunity Analysis |
5.4.17. Others |
5.4.18. Market Analysis, 2018 - 2022 and Forecast, 2023- 2029 (Revenue, USD Mn) |
5.4.19. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.4.20. Market Opportunity Analysis |
6. Global Glycomics/Glycobiology Market, By Application, 2018 - 2022 and Forecast, 2023- 2029 (Revenue, USD Mn) |
6.1. Drug Discovery and Development |
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023- 2029 (Revenue, USD Mn) |
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Diagnostics |
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023- 2029 (Revenue, USD Mn) |
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Others |
6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023- 2029 (Revenue, USD Mn) |
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
7. Global Glycomics/Glycobiology Market, By End User, 2018 - 2022 and Forecast, 2023- 2029 (Revenue, USD Mn) |
7.1. Academic & Research Institutes |
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023- 2029 (Revenue, USD Mn) |
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Pharmaceutical & Biotechnology Companies |
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023- 2029 (Revenue, USD Mn) |
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. CROs |
7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023- 2029 (Revenue, USD Mn) |
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Others |
7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023- 2029 (Revenue, USD Mn) |
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
8. Global Glycomics/Glycobiology Market Forecast, By Region, 2018 - 2022 and Forecast, 2023- 2029 (Revenue, USD Mn) |
8.1. North America |
8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023- 2029 (Revenue, USD Mn) |
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Europe |
8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023- 2029 (Revenue, USD Mn) |
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Asia-Pacific |
8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023- 2029 (Revenue, USD Mn) |
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Latin America |
8.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023- 2029 (Revenue, USD Mn) |
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
8.5. Middle East and Africa |
8.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023- 2029 (Revenue, USD Mn) |
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.5.3. Market Opportunity Analysis |
8.6. Global Glycomics/Glycobiology Market - Opportunity Analysis Index, By Glycomics/Glycobiology, By End User and Region, 2023- 2029 |
9. North America Glycomics/Glycobiology Market Analysis, 2018 - 2022 and Forecast, 2023- 2029 (Revenue, USD Mn) |
9.1. Product Analysis 2018 - 2022 and Forecast 2023- 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
9.1.1. Enzymes |
9.1.1.1. Glycosidases |
9.1.1.2. Neuraminidases |
9.1.1.3. Glycosyltransferases |
9.1.1.4. Sialytransferases |
9.1.1.5. Others |
9.1.2. Kits |
9.1.2.1. Glycan Labelling Kits |
9.1.2.2. Glycan Purification Kits |
9.1.2.3. Glycan Releases Kits |
9.1.2.4. Others |
9.1.3. Reagents |
9.1.3.1. Glycoporteins |
9.1.3.2. Monosaccharides |
9.1.3.3. Oligosaccharides |
9.1.3.4. Others |
9.1.4. Instruments |
9.1.4.1. Mass Spectrometers |
9.1.4.2. HPLC |
9.1.4.3. MALDI-TOF |
9.1.4.4. Array Systems |
9.1.4.5. Others |
9.2. Application Analysis 2018 - 2022 and Forecast 2023- 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
9.2.1. Drug Discovery & Development |
9.2.2. Diagnostics |
9.2.3. Others |
9.3. End User Analysis 2018 - 2022 and Forecast 2023- 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
9.3.1. Academic & Research Institutes |
9.3.2. Pharmaceutical & Biotechnology Companies |
9.3.3. CROs |
9.3.4. Others |
9.4. Country Analysis 2018 - 2022 and Forecast 2023- 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
9.4.1. U.S. |
9.4.2. Canada |
9.5. North America Glycomics/Glycobiology Market - Opportunity Analysis Index, By Glycomics/Glycobiology, End User And Country, 2023- 2029 |
9.6. North America Glycomics/Glycobiology Market Dynamics – Trends |
10. Europe Glycomics/Glycobiology Market Analysis, 2018 - 2022 and Forecast, 2023- 2029 (Revenue, USD Mn) |
10.1. Product Analysis 2018 - 2022 and Forecast 2023- 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
10.1.1. Enzymes |
10.1.1.1. Glycosidases |
10.1.1.2. Neuraminidases |
10.1.1.3. Glycosyltransferases |
10.1.1.4. Sialytransferases |
10.1.1.5. Others |
10.1.2. Kits |
10.1.2.1. Glycan Labelling Kits |
10.1.2.2. Glycan Purification Kits |
10.1.2.3. Glycan Releases Kits |
10.1.2.4. Others |
10.1.3. Reagents |
10.1.3.1. Glycoporteins |
10.1.3.2. Monosaccharides |
10.1.3.3. Oligosaccharides |
10.1.3.4. Others |
10.1.4. Instruments |
10.1.4.1. Mass Spectrometers |
10.1.4.2. HPLC |
10.1.4.3. MALDI-TOF |
10.1.4.4. Array Systems |
10.1.4.5. Others |
10.2. Application Analysis 2018 - 2022 and Forecast 2023- 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
10.2.1. Drug Discovery & Development |
10.2.2. Diagnostics |
10.2.3. Others |
10.3. End User Analysis 2018 - 2022 and Forecast 2023- 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
10.3.1. Academic & Research Institutes |
10.3.2. Pharmaceutical & Biotechnology Companies |
10.3.3. CROs |
10.3.4. Others |
10.4. Country Analysis 2018 - 2022 and Forecast 2023- 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
10.4.1. Germany |
10.4.2. UK |
10.4.3. France |
10.4.4. Spain |
10.4.5. Italy |
10.4.6. Russia |
10.4.7. Poland |
10.4.8. Rest of Europe |
10.5. Europe Glycomics/Glycobiology Market - Opportunity Analysis Index, By Glycomics/Glycobiology, End User And Country, 2023- 2029 |
10.6. Europe Glycomics/Glycobiology Market Dynamics – Trends |
11. Asia-Pacific Glycomics/Glycobiology Market Analysis, 2018 - 2022 and Forecast, 2023- 2029 (Revenue, USD Mn) |
11.1. Product Analysis 2018 - 2022 and Forecast 2023- 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
11.1.1. Enzymes |
11.1.1.1. Glycosidases |
11.1.1.2. Neuraminidases |
11.1.1.3. Glycosyltransferases |
11.1.1.4. Sialytransferases |
11.1.1.5. Others |
11.1.2. Kits |
11.1.2.1. Glycan Labelling Kits |
11.1.2.2. Glycan Purification Kits |
11.1.2.3. Glycan Releases Kits |
11.1.2.4. Others |
11.1.3. Reagents |
11.1.3.1. Glycoporteins |
11.1.3.2. Monosaccharides |
11.1.3.3. Oligosaccharides |
11.1.3.4. Others |
11.1.4. Instruments |
11.1.4.1. Mass Spectrometers |
11.1.4.2. HPLC |
11.1.4.3. MALDI-TOF |
11.1.4.4. Array Systems |
11.1.4.5. Others |
11.2. Application Analysis 2018 - 2022 and Forecast 2023- 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
11.2.1. Drug Discovery & Development |
11.2.2. Diagnostics |
11.2.3. Others |
11.3. End User Analysis 2018 - 2022 and Forecast 2023- 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
11.3.1. Academic & Research Institutes |
11.3.2. Pharmaceutical & Biotechnology Companies |
11.3.3. CROs |
11.3.4. Others |
11.4. Country Analysis 2018 - 2022 and Forecast 2023- 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
11.4.1. Japan |
11.4.2. China |
11.4.3. India |
11.4.4. ASEAN |
11.4.5. Australia & New Zealand |
11.4.6. Rest of Asia-Pacific |
11.5. Asia-Pacific Glycomics/Glycobiology Market - Opportunity Analysis Index, By Glycomics/Glycobiology, End User And Country, 2023- 2029 |
11.6. Asia-Pacific Glycomics/Glycobiology Market Dynamics – Trends |
12. Latin America Glycomics/Glycobiology Market Analysis, 2018 - 2022 and Forecast, 2022 - 2028 |
12.1. Product Analysis 2018 - 2022 and Forecast 2023- 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
12.1.1. Enzymes |
12.1.1.1. Glycosidases |
12.1.1.2. Neuraminidases |
12.1.1.3. Glycosyltransferases |
12.1.1.4. Sialytransferases |
12.1.1.5. Others |
12.1.2. Kits |
12.1.2.1. Glycan Labelling Kits |
12.1.2.2. Glycan Purification Kits |
12.1.2.3. Glycan Releases Kits |
12.1.2.4. Others |
12.1.3. Reagents |
12.1.3.1. Glycoporteins |
12.1.3.2. Monosaccharides |
12.1.3.3. Oligosaccharides |
12.1.3.4. Others |
12.1.4. Instruments |
12.1.4.1. Mass Spectrometers |
12.1.4.2. HPLC |
12.1.4.3. MALDI-TOF |
12.1.4.4. Array Systems |
12.1.4.5. Others |
12.2. Application Analysis 2018 - 2022 and Forecast 2023- 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
12.2.1. Drug Discovery & Development |
12.2.2. Diagnostics |
12.2.3. Others |
12.3. End User Analysis 2018 - 2022 and Forecast 2023- 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
12.3.1. Academic & Research Institutes |
12.3.2. Pharmaceutical & Biotechnology Companies |
12.3.3. CROs |
12.3.4. Others |
12.4. Country Analysis 2018 - 2022 and Forecast 2023- 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
12.4.1. Brazil |
12.4.2. Mexico |
12.4.3. Argentina |
12.4.4. Rest of Latin America |
12.5. Latin America Glycomics/Glycobiology Market - Opportunity Analysis Index, By Glycomics/Glycobiology, End User And Country, 2023- 2029 |
12.6. Latin America Glycomics/Glycobiology Market Dynamics – Trends |
13. Middle East and Africa Glycomics/Glycobiology Market Analysis, 2018 - 2022 and Forecast, 2023- 2029 (Revenue, USD Mn) |
13.1. Product Analysis 2018 - 2022 and Forecast 2023- 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
13.1.1. Enzymes |
13.1.1.1. Glycosidases |
13.1.1.2. Neuraminidases |
13.1.1.3. Glycosyltransferases |
13.1.1.4. Sialytransferases |
13.1.1.5. Others |
13.1.2. Kits |
13.1.2.1. Glycan Labelling Kits |
13.1.2.2. Glycan Purification Kits |
13.1.2.3. Glycan Releases Kits |
13.1.2.4. Others |
13.1.3. Reagents |
13.1.3.1. Glycoporteins |
13.1.3.2. Monosaccharides |
13.1.3.3. Oligosaccharides |
13.1.3.4. Others |
13.1.4. Instruments |
13.1.4.1. Mass Spectrometers |
13.1.4.2. HPLC |
13.1.4.3. MALDI-TOF |
13.1.4.4. Array Systems |
13.1.4.5. Others |
13.2. Application Analysis 2018 - 2022 and Forecast 2023- 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
13.2.1. Drug Discovery & Development |
13.2.2. Diagnostics |
13.2.3. Others |
13.3. End User Analysis 2018 - 2022 and Forecast 2023- 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
13.3.1. Academic & Research Institutes |
13.3.2. Pharmaceutical & Biotechnology Companies |
13.3.3. CROs |
13.3.4. Others |
13.4. Country Analysis 2018 - 2022 and Forecast 2023- 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
13.4.1. Gulf Cooperation Council (GCC) Countries |
13.4.2. Israel |
13.4.3. South Africa |
13.4.4. Rest of MEA |
13.5. MEA Glycomics/Glycobiology Market - Opportunity Analysis Index, By Glycomics/Glycobiology, End User And Country, 2023- 2029 |
13.6. MEA Glycomics/Glycobiology Market Dynamics – Trends |
14. Competition Landscape |
14.1. Strategic Dashboard of Top Market Players |
14.1.1. Company Profiles (Introduction, Financial Analysis, Key Developments, Strategies, and SWOT Analysis) |
14.1.2. Thermo Fisher Scientific, Inc. (US) |
14.1.3. Merck KGaA (Germany) |
14.1.4. Agilent Technologies (US) |
14.1.5. Bruker Corporation (US) |
14.1.6. New England Biolabs (US) |
14.1.7. Danaher Corporation (US) |
14.1.8. Shimadzu Corporation (Japan) |
14.1.9. Takara Bio, Inc. (Japan) |
14.1.10. Waters Corporation (US) |
14.1.11. S-BIO (subsidiary of Sumitomo Bakelite Co. Ltd., Japan) |
14.1.12. RayBiotech (US) |
14.1.13. Z Biotech (US) |
14.1.14. Chemily Glycoscience (US) |
14.1.15. Dextra Laboratories (UK) |
14.1.16. Lectenz Bio (US) |
14.1.17. Ludger Ltd. (UK) |
14.1.18. Asparia Glycomics S.L. (Spain) |
14.1.19. Bio-Techne (US) |
14.1.20. Other Companies |
15. Research Methodology |
16. Key Assumptions and Acronyms |